It’s not just obesity. Drugs like Ozempic will change the world
It is early days yet, but glp-1 receptor agonists have all the makings of one of the most successful classes of drugs in history.
Every day seems to bring more exciting news. First, the drugs tackled diabetes. Then, with just an injection a week, they took on obesity. Now, they are being found to treat cardiovascular and kidney disease, and are being tested for Alzheimer’s and addiction.
It is early days yet, but glp-1 receptor agonists have all the makings of one of the most successful classes of drugs in history. As they become cheaper and easier to use, they promise to dramatically improve the lives of more than a billion people – with profound consequences for industry, the economy and society.
The Economist
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Health & wellness
Fetching latest articles